Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
Open Access
- 27 April 2022
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 395 (8) , 945-962
Abstract
Recently, hypoglycemic drugs belonging to sodium-glucose cotransporter 2 inhibitors (SGLT2i) have generated significant interest due to their clear cardiovascular benefits for heart failure with preserved ejection fraction (HFpEF) since there are no effective drugs that may improve clinical outcomes for these patients over a prolonged period. But, the underlying mechanisms remain unclear, particularly its effects on ferroptosis, a newly defined mechanism of iron-dependent non-apoptotic cell death during heart failure (HF). Here, with proteomics, we demonstrated that ferroptosis might be a key mechanism in a rat model of high-salt diet-induced HFpEF, characterized by iron overloading and lipid peroxidation, which was blocked following treatment with canagliflozin. Data are available via ProteomeXchange with identifier PXD029031. The ferroptosis was evaluated with the levels of acyl-CoA synthetase long-chain family member 4, glutathione peroxidase 4, ferritin heavy chain 1, transferrin receptor, Ferroportin 1, iron, glutathione, malondialdehyde, and 4-hydroxy-trans-2-nonenal. These findings highlight the fact that targeting ferroptosis may serve as a cardioprotective strategy for HFpEF prevention and suggest that canagliflozin may exert its cardiovascular benefits partly via its mitigation of ferroptosis.Keywords
Funding Information
- Bureau of Science and Technology of Hebei Province (19277787D)
- 2019 Hebei Innovation Capability Promotion Project (199776249D)
This publication has 53 references indexed in Scilit:
- Iron and cancer: more ore to be minedNature Reviews Cancer, 2013
- Iron Metabolism, Hepcidin, and Anemia in Orthotopic Heart Transplantation Recipients Treated with Mammalian Target of RapamycinTransplantation Proceedings, 2013
- mTOR Regulates Cellular Iron Homeostasis through TristetraprolinCell Metabolism, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experienceHeart Asia, 2012
- Iron homeostasis in osteoporosis and its clinical implicationsOsteoporosis International, 2012
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchVeterinary Clinical Pathology, 2012
- Effect of High Fat Loading in Dahl Salt-Sensitive RatsClinical and Experimental Hypertension, 2009
- Development of Heart Failure in Chronic Hypertensive Dahl RatsHypertension, 2006
- The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.Journal of Clinical Investigation, 1994